Which peptides have been studied in sexual & reproductive health research?
-
KisspeptinMetastin
Natural reproductive hormone studied in UK trials for low sexual desire and IVF egg maturation. No UK marketing authorisation identified.
LimitedNot licensed in the UK -
Oxytocin
Natural hormone licensed in the UK for obstetric use; studied separately for social cognition, with mostly negative trial results.
LimitedLicensed for a different use -
PT-141 (Bremelanotide)Bremelanotide
No UK marketing authorisation found; authorised in the US. Selective melanocortin-4 receptor agonist studied for low sexual desire in women.
StrongNot licensed in the UK
Best recorded finding for each peptide in this area
| Peptide | UK status | Finding | Study type | Evidence grade |
|---|---|---|---|---|
| Kisspeptin | Not licensed in the UK | Male HSDD crossover trial | Human trial | Limited |
| PT-141 (Bremelanotide) | Not licensed in the UK | The RECONNECT Phase 3 trials | Human trial | Strong |
About this research area
"Sexual & Reproductive Health Research" covers peptides studied in relation to sexual desire, arousal, reproductive endocrinology and licensed obstetric uses such as labour induction. Evidence in this category includes randomised, placebo-controlled human trials in hypoactive sexual desire disorder using functional neuroimaging and clinical desire/distress endpoints, alongside fertility research into oocyte maturation triggering during IVF. Because this category deals with reproductive and sexual physiology specifically, inclusion here is a statement about the research question studied, never about efficacy, safety or suitability for any individual's circumstances.
9 sources in the library relate to this area. See them.
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.